Overall analysis for the prognostic value of Oct-4 expression for OS in patients with NSCLC. AC, adenocarcinoma; CI, confidence interval; HR, hazard ratio; NSCLC, non-small cell lung cancer; Oct-4, octamer-binding transcription factor 4; OS, overall survival; SCC, squamous cell carcinoma.